Palomar (PLMR) Q2 2026 Earnings Call Transcript

Palomar (NASDAQ:PLMR) reported Q2 2026 gross written premium of $630.5M (+27% YoY) and adjusted net income of $63.8M (+31%), lifting diluted adjusted EPS to $2.36 (+34%). The adjusted combined ratio rose to 76.7% (from 73.1% in Q2 2025) on a higher loss ratio, but annualized adjusted ROE improved to 26.3% (from 23.7%). Management raised full-year adjusted net income guidance to $270M–$280M (~27% growth at the midpoint), introduced a $0.45 quarterly dividend, and repurchased 368,719 shares for $41.0M (avg. ~$111). The company also launched PLMR.Farm, an AI-developed crop policy administration platform, while noting competitive pressure in large commercial earthquake pricing.

Analysis

PLMR is transitioning from a “single-line catastrophe” story into a diversified specialty compounder, which matters more for valuation than the headline loss ratio. The mix shift toward crop, surety, and program casualty should reduce earnings volatility and support a higher-quality multiple, while buybacks and a new dividend signal the balance sheet is now generating more capital than the business can immediately reinvest at scale. That is constructive for mid-teens-to-high-teens ROE names, but it also means the market will eventually demand proof that incremental growth still clears the cost of equity once the easy reserve and investment-income tailwinds normalize.

The most important second-order signal is pricing discipline in commercial earthquake: persistent rate compression below technical levels usually precedes capacity rationalization, not a benign “soft landing.” If PLMR and peers keep stepping away from underearned large-layer shared business, the winners should be admitted/residential specialists and reinsurers with cleaner balance sheets; the losers are the marginal market-share takers whose loss ratios reprice only after a lag. Crop and surety are useful offsets, but they are also less stable than the market may assume—crop is inherently seasonally front-loaded and can create a misleadingly weak Q2/Q3 optics window before premium earns through.

The near-term setup is likely messy: Q3 should be the noisiest period because crop losses hit before the premium does, so a sequential margin dip is probably not a thesis break. The real catalyst path is 1-3 months, when acreage reporting, cat renewal economics, and any evidence that earthquake rate declines are moderating will tell us whether this is durable growth or just a late-cycle mix shift. The contrarian risk is that the market over-credits reserve releases and capital return as permanent earnings power; if reserve favorability fades and crop normalizes to a less favorable combined ratio, the multiple can compress even if reported EPS stays respectable.

Key Decisions for Investors

• Buy PLMR on any post-earnings weakness or if the stock digests the Q3 crop-driven margin noise; use a 1-3 month horizon. Thesis: the market will eventually pay for 20%+ ROE, capital return, and reduced concentration risk, while the next quarter likely looks temporarily worse than the economics.
• Pair trade: long PLMR / short KIE for the next 3-6 months. Rationale: PLMR has idiosyncratic growth + capital return, while KIE is a cleaner way to hedge broader insurance multiple compression if the market starts to discount the late-cycle catastrophe pricing environment.
• Sell downside insurance on PLMR only if you already own the name: consider a 3-6 month put spread rather than outright shorting. The stock is likely supported by buybacks/dividend, but the cleanest reversal signal would be a Q3 update that shows commercial earthquake pricing still deteriorating and guidance not being raised.
• Watch item, not a trade yet: if commercial earthquake renewal rates stay down >10-15% for another quarter and new-business pricing remains below technical levels, reduce exposure to earthquake-exposed specialty carriers and rotate toward names with less cat beta and more fee-like/fragmented earnings streams.